KKR
Allied Medical talks complicate Healthscope situation
The $1.6 billion takeover bid for Australian private hospital and pathology operator Healthscope by a consortium of the Blackstone Group, the Carlyle Group, and TPG Capital, with a rival bid from Kohlberg Kravis Roberts & Co., has been complicated by...
Industry Q&A: Glenn Hubbard
AVCJ spoke to Glenn Hubbard, Dean of the Columbia Business School and former Chairman of the Council of Economic Advisers to George W. Bush, about current US attitudes toward private equity investment in Asia.
KKR, Permira cited for MBK CNS sale
Kohlberg Kravis Roberts & Co. and UK-headquartered Permira are among potential bidders for China Network Systems (CNS), the Taiwanese cable TV asset that MBK Partners is seeking to exit for up to $2.5 billion, according to reports.
KKR nixes CVC partnership on Healthscope
Kohlberg Kravis Roberts & Co. has said that CVC Capital Partners will not be participating in a bid for Australia's Healthscope, estimated at potentially up to A$1.84 billion ($1.56 billion), with KKR continuing on the bid by itself.
Japan, a Catch-22?
While Japan's estimated GDP growth sits at just 2.6%, China is forecasted to hit 9.6% growth in 2010.
KKR completes Intelligence acquisition in Japan
Kohlberg Kravis Roberts & Co. has signed a definitive agreement for the buyout of Intelligence Ltd., the recruitment services subsidiary of Tokyo-based cable broadcaster and media content provider Usen, for JPY32.5 billion ($358 million), with both parties...
Blackstone could exit Emcure
The Blackstone Group may be on the verge of exiting its first investment in India, Emcure Pharmaceuticals, following earlier reports that Kohlberg Kravis Roberts & Co. may be about to commit $50 million to the company - the same amount as Blackstone's...
KKR supports Sajjan Jindal India steel
Kohlberg Kravis Roberts & Co. has made an INR650 crore ($140 million) commitment to India's Sajjan Jindal group, cited as India's richest private steel producer, in a structured sponsored finance package mixing debt, equity and cash, to support the group's...
KKR seeks Intelligence in Japan
US private equity giant Kohlberg Kravis Roberts & Co outbid rival the Carlyle Group and local private equity player Advantage Partners to reach final round talks with Intelligence Ltd., a recruitment services subsidiary of Usen Corp, Japan’s wire broadcasting...
KKR in final talks with USEN for Intelligence
US private equity giant Kohlberg Kravis Roberts & Co. has outbid global rival the Carlyle Group and local private equity player Advantage Partners to go into the final round for the acquisition of Japan's Intelligence Ltd., the recruitment services subsidiary...
KKR's Mid East MD head said joining Barclays
Makram Azar, a Kohlberg Kravis Roberts & Co. MD heading the firm’s Middle East and North Africa operations, has reportedly been poached by Barclays Capital to be its head of investment banking for the region.
Tenet backs out of Healthscope, citing disclosure
US hospitals group Tenet Healthcare Corp. has announced its withdrawal from bidding for Australian hospitals and pathology business Healthscope Ltd., leaving the two rival private equity consortia - Kohlberg Kravis Roberts & Co. and CVC Capital Partners...
Tenet could be out for Healthscope
US hospitals group Tenet Healthcare Corp. may withdraw from bidding for Australian hospitals and pathology business Healthscope Ltd., leaving competition for the A$1.84 billion ($1.56 billion) deal to the two rival private equity consortia of Kohlberg...
CVC said joining KKR Healthscope bid
CVC Capital Partners may be joining Kohlberg Kravis Roberts & Co. in its A$1.84 billion ($1.56 billion) bid for Australia's Healthscope Ltd., in contention against a consortium of the Carlyle Group and TPG Capital, as well as Dallas-headquartered US strategic...
KKR, others cited for Healthscope
Kohlberg Kravis Roberts & Co. and an unnamed strategic bidder have been cited as the latest contenders for Australia's Healthscope Ltd., entering bids of around A$1.84 billion ($1.56 billion), marginally above the A$1.8 billion ($1.5 billion) already...
KKR may invest India's Emcure
Kohlberg Kravis Roberts & Co. may be on the point of committing around $50 million into India's Emcure Pharmaceuticals, which until recently was also in discussions with the Blackstone Group, according to Indian sources.
CSRC review of MS CICC stake sale begins
Morgan Stanley has begun the formal application process to the China Securities Regulatory Commission (CSRC) for the sale of its 34.3% stake in PRC investment bank China International Capital Corp. (CICC).
Goldman Sachs close to Taikang win
A consortium led by Goldman Sachs is close to finalizing negotiations for the 15.6% stake in the PRC's Taikang Life Insurance Corp. owned by France’s insurance giant AXA, for about $1 billion.
Keeping LPs happy
Fund administration services becoming more popular as investors become more demanding
KKR solidifies India cement with Dalmia
Kohlberg Kravis Roberts & Co. has agreed an investment of around INR750 crore ($164 million) into Dalmia Cement (Bharat), for a c.20% stake in unlisted subsidiary Avnija, which will house the group's cement manufacturing capacity to create India's largest...
CVC fastens Acument Asian assets deal
CVC Capital Partners has won an auction against Kohlberg Kravis Roberts & Co. and Unitas Capital for the Asian assets of fastener manufacturer Acument Global Technologies, estimated at around $300 million.
OB refinancing, IPO on cards
Several banks have submitted unsolicited proposals for the refinancing of the $1 billion five-year leverage loan that underwrote Kohlberg Kravis Roberts and Affinity Equity Partners' $1.8 billion buyout of Korea's Oriental Brewery in 2009, amid talk of...
PEP, CHAMP in Loscam second round?
CHAMP Private Equity and Pacific Equity Partners have been instanced as potential buyers in a second bidding round for the putative A$500-700 million ($460-640 million) sale of Affinity Equity Partners Australian investee Loscam.
Taizinai puts China risk on show
Actis, Goldman, Morgan Stanley stand to lose